Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 4 Recurrence 2 Infections 1

Interventions

ziprasidone 1 tocilizumab 1 talquetamab 1 idecabtagene vicleucel 1 golimumab 1 gilteritinib 1 anifrolumab 1 Zolpidem 1 X-Rays 1 Wearable Electronic Devices 1 Watchful Waiting 1 Warfarin 1 Vital Signs 1 Vecuronium Bromide 1 Vancomycin 1 Tumor Necrosis Factor Inhibitors 1 Tranexamic Acid 1 Tobramycin 1 Spironolactone 1 Sevelamer 1 Rocuronium 1 Rituximab 1 Procalcitonin 1 Piperacillin, Tazobactam Drug Combination 1 Pentobarbital 1 Oxycodone 1 Nifedipine 1 Nafcillin 1 Molindone 1 Methylprednisolone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Infections × gilteritinib × Clear all

NCT05791890 2023-03-30

GilteRInf

University of Rome Tor Vergata

Other hematologic neoplasm

Infections, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡